A fierce bidding war is underway for Metsera, an obesity drug developer. Novo Nordisk has made a $10 billion offer, which Metsera considers...

PFE stock: Pfizer's stock surged following a report of stronger-than-expected earnings, driven by robust sales of COVID-19 products and key...

Strong Covid product sales and cost-cutting initiatives drove Pfizer's $17.76 billion in revenue in Q4, exceeding Wall Street's projections...

Pfizer lifted its annual earnings forecast on Wednesday and reported a first-quarter profit above Wall Street estimates, boosted by cost cu...

Revenue from Pfizer's COVID-19 vaccine and treatment, which peaked at $57 billion in 2022, are now expected to be $8 billion in 2024, a fur...

These include US approval for a drug combination for prostate cancer and a needed recommendation on the Abrysvo vaccine from the US Centers...

After the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...

Driven by an unprecedented vaccination drive against the COVID-19 pandemic globally, Pfizer's shot has quickly become one of the best-selli...

J&J said it expects full-year sales of $91.3 billion-$92.1 billion this year from the rest of the business, and $93.8 billion to $94.6 bill...

Pfizer said it had supplied 65 million doses globally and 29 million doses in the United States as of Jan. 31. It expects to supply 200 mil...

Analysts now expect per-share earnings from S&P 500 companies to decline 2.1% in the first quarter and fall 1.1% over the following period.

Pfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...

Pfizer Inc said on Tuesday that revenue in the third quarter jumped 39 per cent, but hefty charges related to that $68 billion purchase dra...

Pfizer Inc posted a 2 percent drop in first-quarter profit Tuesday, as cost-cutting by the world's largest drugmaker couldn't offset big dr...

Pfizer, the world’s biggest drugmaker, said profit tripled because of higher sales of the pain pill Lyrica and lower costs from the 11,000 ...

Health care products maker Johnson & Johnson on Tuesday posted a 9 percent increase in its second-quarter profit

Consumer-oriented companies are early leaders among US stocks this year. Earnings reports that start pouring in from Wednesday are likely t...